Geron: From Launch Hype To Later-Line Gravity [Seeking Alpha]
Geron Corporation (GERN)
Last geron corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
geron.com/investors
Company Research
Source: Seeking Alpha
RYTELO faces flat demand, high discontinuation rates, and gross-to-net pressure, with management shifting focus to cost-cutting and restructuring. Layoffs of nearly a third of staff aim to reduce 2026 opex below 2025's ~$250 million, signaling limited near-term revenue acceleration. Myelofibrosis indication is now a long-dated option, with pivotal data not expected until 2H 2028, keeping GERN's outlook challenged. Richard Drury/DigitalVision via Getty Images Introduction Geron's stock ( GERN ) has underperformed the index ( SPY ) since my last look in May. Recall that Geron markets RYTELO in myelodysplastic syndrome, or MDS. While the drug is useful in certain patients, its This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compen
Show less
Read more
Impact Snapshot
Event Time:
GERN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GERN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GERN alerts
High impacting Geron Corporation news events
Weekly update
A roundup of the hottest topics
GERN
News
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Geron Corporation (GERN) Restructuring to Lower Operating Expenses as it Eyes Profitability in 2026 [Yahoo! Finance]Yahoo! Finance
- Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On The Sidelines [Seeking Alpha]Seeking Alpha
- Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation [Yahoo! Finance]Yahoo! Finance
GERN
Earnings
- 11/5/25 - In-Line
GERN
Sec Filings
- 12/16/25 - Form 8-K
- 12/15/25 - Form 144
- 11/7/25 - Form 10-Q
- GERN's page on the SEC website